News
New clinical trial results reveal gedatolisib significantly improves progression-free survival in advanced HR+/HER2– breast ...
Major stock indexes edged higher Monday to kick off what will be an extraordinarily busy week of news for financial markets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results